دورية أكاديمية

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial.

التفاصيل البيبلوغرافية
العنوان: The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial.
المؤلفون: Hansen, Julie Schjødtz, Hansen, Rikke Middelhede, Petersen, Thor, Gustavsen, Stefan, Oturai, Annette Bang, Sellebjerg, Finn, Sædder, Eva Aggerholm, Kasch, Helge, Rasmussen, Peter Vestergaard, Finnerup, Nanna Brix, Svendsen, Kristina Bacher
المصدر: Brain Sciences (2076-3425); Sep2021, Vol. 11 Issue 9, p1212-1212, 1p
مصطلحات موضوعية: SPASTICITY, NEURALGIA, SPINAL cord injuries, MULTIPLE sclerosis, RESEARCH protocols, PAIN medicine, PAIN
مستخلص: Disease or acquired damage to the central nervous system frequently causes disabling spasticity and central neuropathic pain (NP), both of which are frequent in multiple sclerosis (MS) and spinal cord injury (SCI). Patients with MS and SCI often request treatment with cannabis-based medicine (CBM). However, knowledge about effects, side effects, choice of active cannabinoids (Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD) alone or in combination), and doses of CBM remains limited. Using a double-blind, parallel design in a national multicenter cohort, this study examines the effect of CBM on spasticity and NP. Patients are randomized to treatment with capsules containing either THC, CBD, THC and CBD, or placebo. Primary endpoints are patient-reported pain and spasticity on a numerical rating scale. Other endpoints include quality of life and sleep, depression and anxiety, and relief of pain and spasticity. Side-effects of CBM are described. In a sub-study, the pharmacodynamics (PD) and pharmacokinetics (PK) of oral capsule CBM are examined. We expect that the study will contribute to the literature by providing information on the effects and side-effects of CBD, THC, and the combination of the two for central neuropathic pain and spasticity. Furthermore, we will describe the PD/PK of THC and CBD in a patient population. [ABSTRACT FROM AUTHOR]
Copyright of Brain Sciences (2076-3425) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20763425
DOI:10.3390/brainsci11091212